• E Cho, K Youn, H Kwon, H Bae, M Moon, MJun*, DH Kim. 2, 3, 4-Trihydroxybenzophenone Disassembles Amyloid β Aggregates and Ameliorates Synaptic Deficits. 2026. Pharmaceutics 18, 320

• CK Marasinghe, K Youn, CT Ho, MJun*. Targeting the Cardiovascular-Alzheimer's Disease Axis: The Promise of Marine Bioactive Peptides. 2026.Marine Drugs 24, 56

• K Youn, LM Soriano,MJun*. Structural and Mechanistic Insights into Dual Cholinesterase Inhibition by Marine Phytohormones. 2026. Marine Drugs 24, 35

• N Lee, K Youn, H Kwon, J Lee, E Lee, JW Jung, M Moon, DS Lee, DH Kim, CT Ho, MJun*. Fucoxanthin Suppresses Amyloid-β and Pyroglutamate-3-Aβ Accumulation by Modulating PI3K/Akt/GSK-3β Signaling Pathway. Published online November 6, 2025. Food & Functiondoi:10.1039/d5fo04217h

• A Javed, K Youn, CT Ho, MJun*. Unveiling the preventive potential of artesin in brain-heart Axis: In-silico insights into Alzheimer's and cardiovascular diseases prevention. 2025. Computers in Biology and Medicine 196, 110866

• A Javed, K Youn, CT Ho, MJun*. Exploring the heart-brain axis: Network pharmacological analysis of 10 Saudi Arabian spices in Alzheimer's and cardiovascular diseases. 2025. Computers in Biology and Medicine 195, 110576

• K Youn, CT Ho, MJun*. Investigating the Potential Anti-Alzheimer’s Disease Mechanism of Marine Polyphenols: Insights from Network Pharmacology and Molecular Docking. 2023. Marine Drugs 21 (11), 580

• N Lee, K Youn, JH Yoon, B Lee, DH Kim, MJun*. The Role of Fucoxanthin as a Potent Nrf2 Activator via Akt/GSK-3β/Fyn Axis against Amyloid-β Peptide-Induced Oxidative Damage. 2023. Antioxidants 12 (3), 629

• K Youn, CT Ho, MJun*. Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: An overview of pre-clinical studies focused on β-amyloid peptide. 2022. Food Science and Human Wellness 11 (3), 483-493

• E Cho, K Youn, H Kwon, J Jeon, WS Cho, SJ Park, SH Son, DS Jang, CY Shin, M Moon, MJun*, NJ Kim, DH Kim. Eugenitol ameliorates memory impairments in 5XFAD mice by reducing Aβ plaques and neuroinflammation. 2022. Biomedicine & Pharmacotherapy 148, 112763

• JH Yoon, K Youn, MJun*. Protective effect of sargahydroquinoic acid against Aβ25?35-evoked damage via PI3K/Akt mediated Nrf2 antioxidant defense system. 2021. Biomedicine & Pharmacotherapy 144, 112271

• JH Yoon, N Lee, K Youn, MR Jo, HR Kim, DS Lee, CT Ho, MJun*. Dieckol ameliorates Aβ production via PI3K/Akt/GSK-3β regulated APP processing in SweAPP N2a Cell. 2021. Marine Drugs 19 (3), 152

• J Yu, E Cho, H Kwon, J Jeon, JS Sin, JK Park, JS Kim, JW Choi, SJ Park, MJun*, YC Lee, JH Ryu, J Lee, M Moon, S Lee, JH Cho, DH Kim. Akt and calcium-permeable AMPA receptor are involved in the effect of pinoresinol on amyloid β-induced synaptic plasticity and memory deficits. 2021. Biochemical Pharmacology 184, 114366

• J Hwang, K Youn, G Lim, J Lee, DH Kim, MJun*. Discovery of Natural Inhibitors of Cholinesterases from Hydrangea: In Vitro and In Silico Approaches. 2021. Nutrients 13 (1), 254